DALLAS, January 27, 2015 /PRNewswire/ --
ReportsnReports.com offers IVD (In Vitro Diagnostic) Testing World Markets industry research report of 339 pages published in Jan 2015 under its healthcare market intelligence collection of its online research and data library.
In vitro diagnostic (IVD) testing is experiencing a revival fueled by a combination of technological improvements, cost pressures, reimbursement changes, rapid growth in molecular diagnostics and increasing interest in the genomics testing. Recent advances in molecular diagnostics technologies--including sequencing, PCR and microarray--are enabling greater sensitivity and precision in nucleic acid measurements, further expanding manufacturers' offerings. Complete report on IVD (In Vitro Diagnostic) Testing World Markets is available at http://www.reportsnreports.com/reports/330446-ivd-in-vitro-diagnostic-testing-world-markets.html .
This IVD market report is an overview of each major in vitro diagnostic testing segment, including: point of care testing (POCT), molecular diagnostics, chemistry, diabetes and glucose, immunoassay, hematology, coagulation, pathology, microbiology, histology and cytology, and blood banking. For each segment, this study examines the generally accepted clinical analytical activities in use today. Moreover, the analysis here discusses the potential benefits of the diagnostics techniques, as well as provides market size and future growth potential. Additionally, this report assesses the various business models, including CLIA-licensed specialty labs, general reference labs and reagent kit marketing. This study also examines hundreds of companies that are actively developing and marketing IVD testing products around the world. This report analyzes the size and growth of the important sectors of the diagnostics market, including the drivers and restraints that influence the various market segments, as well as the dollar volume of sales and market growth rates, both in the U.S. and worldwide.
Regionally, this in-vitro diagnostic testing market research provides summary analysis of the IVD high-growth market in U.S., Europe, South East Asia and Japan and BRIC (Brazil, Russia, India and China) countries. Key market drivers and barriers to growth are also discussed in this report.
Companies discussed in this IVD testing industry research's multiple sections and segments include Myriad Genetics (BRCA1 and BRCA2), Genomic Health (Oncotype DX), InterGenetics, Inc. 77, Clarient, Inc. (GE Healthcare), BioTheronostics , Agendia B.V. (MammaPrint), LabCorp, Quest Diagnostics, Abbott Diagnostics, Siemens, Roche, Beckman Coulter, Inc., bioMérieux, Ortho-Clinical Diagnostics, Ventana Medical Systems Inc. (part of Roche's Diagnostics Division), Dako (An Agilent Technologies Company), Aperio(Part of Leica Biosystems), Abbott Laboratories, Omnyx, LLC (Part of GE Healthcare) and Visiopharm.
174 Companies profiled in this in-vitro diagnostic testing market report cover A. Menarini, Abaxis, Inc., Abbott Laboratories, Accriva Diagnostics, Inc., Adaltis, AdnaGen, AdvanDx, Affymetrix, Inc., Agendia, Agilent Technologies, ALERE, INC., Alfa Scientific Designs, Inc., Alfa Wasserman, Inc., ALPHELYS, AMS, Ambry Genetics, ArcticDx, Inc., Ariosa Diagnostics, Inc., ARKRAY USA, Inc., Asuragen, Inc., Atlas Genetics, Atonomics A/S, AutoGenomics, Inc., Awareness Technology, Axxin, Bayer, BD, Beckman Coulter Genomics, Inc., Biocartis SA, BioCytex, Biodata (Microlink Engineering Systems), BioData Ltd., Biodesix, BioGenex Laboratories, Inc., BioFire Diagnostics, Inc. (Part of bioMérieux now), BioMedomics, bioMérieux, Biophor Diagnostics, Bio-Rad, Biosensia Ltd., Biosite Diagnostics (part of Alere), Biotage AB, bioTheranostics, Cancer Genetics, Inc., Caris Life Sciences, Cepheid, Celula, Inc., Chembio Diagnostics, Inc., Clarient, Coagusense, Inc., CombiMatrix Corporation, Curetis AG, Cyber Medical Ltd., Dako A/S (Agilent Technologies), Debiotech, DexCom , Diagnostica Stago, Inc., Diagnostica Stago S.A.S, Diagnostics for All, DiaSorin S.p.A., DxNA, LLC. , Echo Therapeutics, Eiken Chemical Company Limited, Enigma Diagnostics Limited, Epigenomics, Exact Sciences Corporation, Exagen Diagnostics, Inc., Exiqon, Exosome Diagnostics, FIFTY50 Medical, Inc., Fluidigm Corporation, Fujirebio Inc., GE Healthcare, Genera Biosystems, GenMark Diagnostics, Inc., Genomica S.A.U. , Genomic Health, Inc., Genomix Biotech, Genoptix, Inc., Gentag, Inc., Great Basin Corporation, Grifols, Haemonetics Corporation, Hologic Gen-Probe, Hutman Diagnostics, AG, Hy Laboratories Ltd., HYPHEN BioMed, Ikonisys Inc., Illumina, Inc. , Immunexpress Group, Infopia Co., Ltd., Innovative Biosensors, Inc., Integrity Applications, InterGenetics, Inc., Integrated Diagnostics, International Technidyne Corp (THORATEC CORP), Instrumentation Laboratory, IQuum, Inc.(acquired by Roche), iSense Corporation (subsidiary of BayerAG), JEOL Ltd., Johnson & Johnson, Kommanditgesellschaft Behnk Elektronik GmbH & Co., Kyowa Medex, LabCorp, Labor BioMedical Technologies GmbH (LABiTec), Leica Biosystems, Life Technologies Corporation, Luminex Corporation, Lumora Ltd., M-Biotech, MBio Diagnostics, Inc., MDxHealth, Medica Corporation, Inc., Medtronic, Menssana Research, Inc., Meridian Biosciences, Metaara Medical Technologies Inc., Miraculins Inc. , Mobidiag, Myriad Genetics, Inc , Nanosphere , Nanostring, Natera Inc., Neogenomics, Nipro Diagnostics, Nova Biomedical Corporation, Novartis, Novo Nordisk, Nuvera Biosciences, OraSure, Ortho Clinical Diagnostics (Formerly a Johnson & Johnson Company), Pfizer, Inc.. Phamatech, Inc., Pharma Supply, Inc., Polymedco, Prodigy Diabetes Care, LLC (formerly Diagnostic Devices, Inc.), Qiagen NV, Quidel Corporation, Radient Pharmaceuticals Corporation, Randox, Roche AG, Rosetta Genomics Ltd., Sanofi, Seegene, Sekisui Diagnostics, Sensors for Medicine and Science, Sequenom, Inc., Shimadzu Corporation, Siemens AG, Siemens Healthcare Diagnostics, Sienco Inc., Simple Diagnostics, SIRS-Lab, Smiths Medical, Source MDx, Spartan Bioscience, Spectrum Laboratories, Inc., Sysmex America, Inc., Technoclone Gmbh, Telcare, Thermo Fisher Scientific, Inc., TrimGen, TrovaGene, Trinity Biotech plc, U.S. Diagnostics, Universal Biosensors, Inc., Ventana, VeraLight, Veredus Laboratories, Veridex (a Johnson & Johnson company), Visiopharm, Wako, WILEX AG and ZS Genetics. Order a copy of this IVD testing report at http://www.reportsnreports.com/Purchase.aspx?name=330446 .
Few recent coagulation testing sector activities discussed in this research include Roche and Diagnostica Stago Parting Ways in Laboratory Coagulation, Roche Acquires Verum Diagnostica GmbH and Expands Coagulation Testing Product Line, Universal Biosensors and Siemens Collaborate on Advanced POC Coagulation Platform, Instrumentation Laboratory and Beckman Coulter concluded their Cross-Distribution Agreement, CoaguChek XS Personal Receives Reimbursement Approval for Self-Testing in Japan, Diagnostica Stago Launches Products for Measurement of Rivaroxaban, Diagnostic Stago Offers Three Factor VII Detection Methods, Diagnostica Stago Offers Three Procoagulant Microparticle Detection Methods, Diagnostica Stago S.A.S enters into Joint Research Agreement with Bristol-Myers Squibb, Trinity Biotech Sold its Worldwide Coagulation Business to the Stago Group, Alere aka Inverness Medical Innovations Acquired HemoSense, Inc. and Alere Announced Positive Results in Clinical Study Evaluating At-Home Coagulation Testing.
Explore more reports on the in-vitro diagnostics market as well as the IVD industry at http://www.reportsnreports.com/tags/ivd-market-research.html .
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.
Ritesh Tiwari / Priyank Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Connect with Us:
G+ / Google Plus: https://plus.google.com/u/0/111656568937629536321/posts